Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-selective
100%
Benzodiazepine Site
100%
Anxiolysis
100%
TP003
100%
GABAA Receptor (GABAAR)
57%
Benzodiazepines
28%
Clinical Application
14%
Triple Point
14%
Highly Effective
14%
Undesired Effects
14%
Mediating Effect
14%
Genetically Engineered Mice
14%
Anxiety Disorders
14%
Receptor 1
14%
Single Compounds
14%
Selective Agents
14%
Pharmacological Approaches
14%
Subtype Selectivity
14%
Pharmacological Profile
14%
Pre-clinical and Clinical Trials
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Mouse Mutant
100%
Benzodiazepine
100%
Side Effect
50%
Clinical Trial
50%
Preclinical Study
50%
4 Aminobutyric Acid
50%
Genetically Engineered Mouse Strain
50%
Anxiety Disorder
50%
Medicine and Dentistry
Receptor
100%
Tranquilizing Activity
100%
Benzodiazepine Derivative
100%
Benzodiazepine
100%
In Vitro
50%
Gamma-Aminobutyric Acid
25%
GABAA Receptor
25%
Clinical Trial
25%
Side Effect
25%
Anxiety Disorder
25%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Benzodiazepine
100%
Tranquilizing Activity
100%
Mouse Mutant
66%
Clinical Trial
33%
Preclinical Study
33%
Genetically Engineered Mouse Strain
33%
GABAA Receptor
33%
Gamma-Aminobutyric Acid
33%
Neuroscience
Agonist
100%
Benzodiazepine
100%
Receptor
100%
In Vitro
66%
In Vivo
33%
GABAA Receptor
33%
Gamma-Aminobutyric Acid
33%
Anxiety Disorder
33%